Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6368760 | 0.76 | TSHR (0.34) | USP2TSHRCA1CA2 | |
| SCHEMBL6042912 | 0.76 | ALDH1A1 (0.44) | USP2TSHRCA1CA2 | |
| SCHEMBL5475756 | 0.76 | TSHR (0.31) | TSHR | |
| SCHEMBL6364749 | 0.76 | CA2 (0.38) | USP2TSHRCA1CA2 | |
| SCHEMBL28763788 | 0.71 | ALDH1A1 (0.30) | TSHR | |
| 1,1-Dichloroethene SCHEMBL7550414 | 0.71 | USP2 (0.31) | USP2TSHRCA1CA2 | |
| SCHEMBL3339906 | 0.71 | CA1 (0.34) | USP2TSHRCA1CA2 | |
| Butane SCHEMBL3095446 | 0.70 | TSHR (0.44) | TSHR | |
| SCHEMBL5094525 | 0.69 | TSHR (0.38) | USP2TSHRCA1CA2 | |
| SCHEMBL124310 | 0.68 | THRB (0.36) | TSHRCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4599030-B1 | A PYROLYSIS OIL WITH REDUCED POUR POINT | EVONIK OPERATIONS GMBH (DE) | 2026-03-25 | — | — | EP | claimed |
| EP-4594452-B1 | A PYROLYSIS OIL WITH REDUCED POUR POINT AND/OR VISCOSITY | EVONIK OPERATIONS GMBH (DE) | 2025-12-10 | — | — | EP | claimed |
| EP-4599030-A1 | A PYROLYSIS OIL WITH REDUCED POUR POINT | Evonik Operations GmbH (DE) | 2025-08-13 | — | — | EP | claimed |
| EP-4594452-A1 | A PYROLYSIS OIL WITH REDUCED POUR POINT AND/OR VISCOSITY | Evonik Operations GmbH (DE) | 2025-08-06 | — | — | EP | claimed |
| WO-2025132057-A1 | A PYROLYSIS OIL WITH REDUCED POUR POINT | EVONIK OPERATIONS GMBH (DE) | 2025-06-26 | — | — | WO | claimed |
| WO-2025132054-A1 | A PYROLYSIS OIL WITH REDUCED POUR POINT AND/OR VISCOSITY | EVONIK OPERATIONS GMBH (DE) | 2025-06-26 | — | — | WO | claimed |
| US-12606729-B2 | Use of polymeric-inorganic nanoparticle compositions as heat transfer fluids in battery or other electrical equipment systems | EVONIK OPERATIONS GMBH (DE) | 2026-04-21 | — | — | US | disclosed |
| EP-4599030-B1 | A PYROLYSIS OIL WITH REDUCED POUR POINT | EVONIK OPERATIONS GMBH (DE) | 2026-03-25 | — | — | EP | disclosed |
| EP-4594452-B1 | A PYROLYSIS OIL WITH REDUCED POUR POINT AND/OR VISCOSITY | EVONIK OPERATIONS GMBH (DE) | 2025-12-10 | — | — | EP | disclosed |
| US-12415944-B2 | Use of nanoparticle compositions as heat transfer fluids in battery or other electrical equipment systems | EVONIK OPERATIONS GMBH (DE) | 2025-09-16 | — | — | US | disclosed |
| EP-4599030-A1 | A PYROLYSIS OIL WITH REDUCED POUR POINT | Evonik Operations GmbH (DE) | 2025-08-13 | — | — | EP | disclosed |
| EP-4594452-A1 | A PYROLYSIS OIL WITH REDUCED POUR POINT AND/OR VISCOSITY | Evonik Operations GmbH (DE) | 2025-08-06 | — | — | EP | disclosed |
| WO-2025132057-A1 | A PYROLYSIS OIL WITH REDUCED POUR POINT | EVONIK OPERATIONS GMBH (DE) | 2025-06-26 | — | — | WO | disclosed |
| US-6610802-B2 | Polymerizing unsatd. monomers with a transition metal catalyst and a coordination compound-forming ligand; filtration using a filter aid having carboxylic acid-, sulfonic acid- or phosphonic acid-containing units | ROHMAX ADDITIVES GMBH (DE) | 2003-08-26 | — | — | US | disclosed |
| US-20030060587-A1 | Process for synthesis of polymer compositions, polymer compositions obtainable by the process, and use of the same | ROHMAX ADDITIVES GMBH (DE) | 2003-03-27 | — | — | US | disclosed |
| US-20020188081-A1 | Process for synthesis of polymer compositions with reduced halogen content, polymer composition with reduced halogen content as well as use of this composition | ROHMAX ADDITIVES GMBH KIRSCHENALLEE (DE) | 2002-12-12 | — | — | US | disclosed |
| US-6403746-B1 | POLYMERIZING ETHYLENICALLY UNSATURATED ESTERS USING INITIATOR HAVING TRANSFERABLE ATOMIC GROUP AND ONE OR MORE TRANSITION METAL-CONTAINING CATALYSTS, IN PRESENCE OF LIGAND THAT CAN FORM COORDINATION COMPOUND WITH CATALYST AND MINERAL OIL | ROHMAX ADDITIVES GMBH (DE) | 2002-06-11 | — | — | US | disclosed |
| US-6403745-B1 | GRADIENT COPOLYMERS OBTAINED BY POLYMERIZING MIXTURE OF ETHYLENICALLY UNSATURATED ESTERS OBTAINED FROM ALCOHOLS OF DIFFERENT CHAIN LENGTHS, WHERE MIXTURE OF MONOMERS IS VARIED DURING CHAIN GROWTH TO OBTAIN COPOLYMERS HAVING GRADIENT | ROHMAX ADDITIVES GMBH (DE) | 2002-06-11 | — | — | US | disclosed |
| US-6391996-B1 | BLEND CONTAINING ETHYLENICALLY UNSATURATED ESTER | ROHMAX ADDITIVES GMBH (DE) | 2002-05-21 | — | — | US | disclosed |
| US-20020002259-A1 | LOW-ODOR, COLD-CURING (METH) ACRYLATE REACTION RESIN FOR FLOOR COATING, A FLOOR COATING CONTAINING THE REACTION RESIN, AND A PROCESS FOR THE PREPARATION OF THE FLOOR COATING | ROEHM GMBH & CO KG (DE) | 2002-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12606729-B2 | Use of polymeric-inorganic nanoparticle compositions as heat transfer fluids in battery or other electrical equipment systems | ADH1A, MMAB, ACR | USP2 3756/4885TSHR 1919/4885CA1 181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.